Chertov Oleg, Simpson John T, Biragyn Arya, Conrads Thomas P, Veenstra Timothy D, Fisher Robert J
Protein Chemistry Laboratory, National Cancer Institute, SAIC-Frederick Inc., PO Box B, Frederick, MD 21702, USA.
Expert Rev Proteomics. 2005 Jan;2(1):139-45. doi: 10.1586/14789450.2.1.139.
The dramatic progress in mass spectrometry-based methods of protein identification has triggered a new quest for disease-associated biomarkers. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and its variant surface-enhanced laser desorption/ionization mass spectrometry, provide effective means to explore the less studied information slice of the human serum proteome -- low-molecular-weight proteins and peptides. These low-molecular-weight proteins and peptides are promising for the detection of important biomarkers. Due to the significant experimental problems imposed by high-abundance and high-molecular-weight proteins, it is important to effectively remove these species prior to mass spectrometry analysis of the low-molecular-weight serum and plasma proteomes. In this review, the advantages afforded by recently introduced methods for prefractionation of serum, as they pertain to the detection and identification of biomarkers, will be discussed.
基于质谱的蛋白质鉴定方法取得的巨大进展引发了对疾病相关生物标志物的新探索。基质辅助激光解吸/电离飞行时间质谱及其变体表面增强激光解吸/电离质谱,为探索人类血清蛋白质组中研究较少的信息片段——低分子量蛋白质和肽,提供了有效的手段。这些低分子量蛋白质和肽有望用于重要生物标志物的检测。由于高丰度和高分子量蛋白质带来了重大的实验问题,在对低分子量血清和血浆蛋白质组进行质谱分析之前,有效去除这些物质很重要。在这篇综述中,将讨论最近引入的血清预分级方法在生物标志物检测和鉴定方面的优势。